| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Psychology (Dr. Storandt) and Neurology and Pathology and Immunology (Dr. Morris), Division of Biostatistics (Dr. Grant and J.P. Miller), and Alzheimer Disease Research Center (Drs. Storandt, Grant, and Morris, and J.P. Miller), Washington University, St. Louis, MO.
Address correspondence and reprint requests to Dr. John C. Morris, Alzheimer Disease Research Center, 4488 Forest Park Ave., Suite 160, St. Louis, MO 63108; e-mail: morrisj{at}neuro.wustl.edu
Objective: To compare rates of progression in the very mildest stages of AD, including the stage currently identified as mild cognitive impairment (MCI), and to identify predictors of those rates.
Methods: Demented (n = 289) and nondemented (n = 230) individuals enrolled in longitudinal studies at an Alzheimer Disease Research Center received annual clinical and psychometric examinations for up to 20 years. In order of increasing dementia severity, demented individuals were diagnosed with incipient, very mild, or mild dementia; the incipient stage is equivalent to MCI. Outcome measures included death, nursing home placement, and psychometric scores.
Results: Rate of progression increased with dementia severity as staged by the Clinical Dementia Rating at entry into the study. With respect to the dichotomous outcomes, the increase with dementia severity was more dramatic for the endpoint of nursing home entry than it was for the endpoint of death. Increased rates of cognitive decline with increased dementia severity were also obtained for psychometric scores. There was limited evidence of other predictors of progression.
Conclusions: The lack of effective predictors of the rate of dementia progression extends to the very earliest stages of the disease, including what is often called MCI. A new approach to the identification of correlates of rates of progression is needed.
This article has been cited by other articles:
|
|
 |
|
  B. J. Snider, A. M. Fagan, C. Roe, A. R. Shah, E. A. Grant, C. Xiong, J. C. Morris, and D. M. Holtzman Cerebrospinal Fluid Biomarkers and Rate of Cognitive Decline in Very Mild Dementia of the Alzheimer Type Arch Neurol, May 1, 2009; 66(5): 638 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Dickerson, A. Bakkour, D. H. Salat, E. Feczko, J. Pacheco, D. N. Greve, F. Grodstein, C. I. Wright, D. Blacker, H. D. Rosas, et al. The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals Cereb Cortex, March 1, 2009; 19(3): 497 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Britschgi and T. Wyss-Coray Blood Protein Signature for the Early Diagnosis of Alzheimer Disease Arch Neurol, February 1, 2009; 66(2): 161 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A J Mitchell and M Shiri-Feshki Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis J. Neurol. Neurosurg. Psychiatry, December 1, 2008; 79(12): 1386 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Jalbert, L. A. Daiello, and K. L. Lapane Dementia of the Alzheimer Type Epidemiol. Rev., November 1, 2008; 30(1): 15 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. McCarten, L. S. Hemmy, S. J. Rottunda, and M. A. Kuskowski Patient Age Influences Recognition of Alzheimer's Disease J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2008; 63(6): 625 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Jack Jr, S. D. Weigand, M. M. Shiung, S. A. Przybelski, P. C. O'Brien, J. L. Gunter, D. S. Knopman, B. F. Boeve, G. E. Smith, and R. C. Petersen Atrophy rates accelerate in amnestic mild cognitive impairment Neurology, May 6, 2008; 70(19_Part_2): 1740 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cosentino, N. Scarmeas, E. Helzner, M. M. Glymour, J. Brandt, M. Albert, D. Blacker, and Y. Stern APOE {varepsilon}4 allele predicts faster cognitive decline in mild Alzheimer disease Neurology, May 6, 2008; 70(19_Part_2): 1842 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Wilson, J. A. Schneider, P. A. Boyle, S. E. Arnold, Y. Tang, and D. A. Bennett Chronic distress and incidence of mild cognitive impairment Neurology, June 12, 2007; 68(24): 2085 - 2092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Tyas, J. C. Salazar, D. A. Snowdon, M. F. Desrosiers, K. P. Riley, M. S. Mendiondo, and R. J. Kryscio Transitions to Mild Cognitive Impairments, Dementia, and Death: Findings from the Nun Study Am. J. Epidemiol., June 1, 2007; 165(11): 1231 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Csernansky, H. Dong, A. M. Fagan, L. Wang, C. Xiong, D. M. Holtzman, and J. C. Morris Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia Am J Psychiatry, December 1, 2006; 163(12): 2164 - 2169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Boyle, R. S. Wilson, N. T. Aggarwal, Y. Tang, and D. A. Bennett Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline Neurology, August 8, 2006; 67(3): 441 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Storandt, E. A. Grant, J. P. Miller, and J. C. Morris Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI Neurology, August 8, 2006; 67(3): 467 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Marcos, P. Gil, A. Barabash, R. Rodriguez, M. Encinas, C. Fernandez, and J. A. Cabranes Neuropsychological Markers of Progression From Mild Cognitive Impairment to Alzheimer's Disease American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 189 - 196. [Abstract] [PDF]
|
|
|
|
|
|
L. C. Lam, N. L. Tang, S. Ma, V. W. Lui, A. S. Chan, P Y Leung, and H. F. Chiu Apolipoprotein epsilon-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, March 1, 2006; 21(2): 92 - 99. [Abstract] [PDF]
|
|
|
|
|
|
J. C. Morris Mild Cognitive Impairment Is Early-Stage Alzheimer Disease: Time to Revise Diagnostic Criteria Arch Neurol, January 1, 2006; 63(1): 15 - 16. [Full Text] [PDF]
|
|
|
|
|
|
C. H. Wilkins, E. A. Grant, S. E. Schmitt, D. W. McKeel, and J. C. Morris The Neuropathology of Alzheimer Disease in African American and White Individuals Arch Neurol, January 1, 2006; 63(1): 87 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Nordlund, S Rolstad, P Hellstrom, M Sjogren, S Hansen, and A Wallin The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition J. Neurol. Neurosurg. Psychiatry, November 1, 2005; 76(11): 1485 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Petersen and J. C. Morris Mild Cognitive Impairment as a Clinical Entity and Treatment Target Arch Neurol, July 1, 2005; 62(7): 1160 - 1163. [Full Text] [PDF]
|
|
|
|
|
|
D. Head, A. Z. Snyder, L. E. Girton, J. C. Morris, and R. L. Buckner Frontal-Hippocampal Double Dissociation Between Normal Aging and Alzheimer's Disease Cereb Cortex, June 1, 2005; 15(6): 732 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.H.T. Karlawish, D. J. Casarett, B. D. James, S. X. Xie, and S. Y.H. Kim The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment Neurology, May 10, 2005; 64(9): 1514 - 1519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Bennett, J. A. Schneider, J. L. Bienias, D. A. Evans, and R. S. Wilson Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions Neurology, March 8, 2005; 64(5): 834 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Adak, K. Illouz, W. Gorman, R. Tandon, E. A. Zimmerman, R. Guariglia, M. M. Moore, and J. A. Kaye Predicting the rate of cognitive decline in aging and early Alzheimer disease Neurology, July 13, 2004; 63(1): 108 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Head, R. L. Buckner, J. S. Shimony, L. E. Williams, E. Akbudak, T. E. Conturo, M. McAvoy, J. C. Morris, and A. Z. Snyder Differential Vulnerability of Anterior White Matter in Nondemented Aging with Minimal Acceleration in Dementia of the Alzheimer Type: Evidence from Diffusion Tensor Imaging Cereb Cortex, April 1, 2004; 14(4): 410 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Fisk, H. R. Merry, and K. Rockwood Variations in case definition affect prevalence but not outcomes of mild cognitive impairment Neurology, November 11, 2003; 61(9): 1179 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Villareal, E. Grant, J. P. Miller, M. Storandt, D. W. McKeel, and J. C. Morris Clinical outcomes of possible versus probable Alzheimer's disease Neurology, September 9, 2003; 61(5): 661 - 667. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
